TMDI
Titan Medical Inc.
Set alert
0.14 0.00 0.00%
0.135 Day range 0.15
52-week range unavailable
- Open
- 0.14
- Prev close
- 0.14
- Mkt cap
- 16.07M
- Vol
- 7.71M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.135
- High
- 0.15
- Forward P/E
- -0.27
- Beta
- 3.52
- Short ratio
- 0.01
- Inst. own
- 4.56%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 23, 2023
- 50-d avg
- 0.456982
- 200-d avg
- 0.517278
- 1y target
- 2.00
Key statistics
- Market cap
- 16.07M
- Enterprise value
- 11.48M
- Trailing P/E
- 0.00
- Forward P/E
- -0.27
- PEG ratio
- 0.00
- Price / sales
- 1.61
- Price / book
- 2.26
- EPS (TTM)
- -0.16
- Beta
- 3.52
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -210.43%
- Revenue (TTM)
- 10.00M
- Revenue growth
- 0.00%
- Free cash flow
- -33.37M
- Total cash
- 11.64M
- Total debt
- 1.48M
- Return on equity
- -129.90%
- Shares outstanding
- 111.89M
- Short % of float
- 0.05%
- 50-day average
- 0.456982
- 200-day average
- 0.517278
Analyst view
Consensus: hold
Hold
Price target (mean) 2.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Mar 23, 2023
Expected Mar 23, 2023. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 23, 2023 | Dec 1, 2022 | 0.00 | — | — | — |
| Nov 10, 2022 | Sep 1, 2022 | 0.00 | — | — | — |
| Aug 11, 2022 | Jun 1, 2022 | 0.00 | — | — | — |
| May 12, 2022 | Mar 1, 2022 | -0.10 | — | — | — |
| Mar 24, 2022 | Dec 1, 2021 | -0.13 | — | — | — |
| Nov 11, 2021 | Sep 1, 2021 | -0.06 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 25, 2022 | Oppenheimer | down | Outperform | Perform |
| Apr 7, 2021 | Oppenheimer | init | — | Outperform |
| Oct 16, 2019 | Maxim Group | down | Buy | Hold |
| May 22, 2019 | Piper Jaffray | init | — | Overweight |
| Sep 17, 2018 | Northland Securities | init | — | Outperform |
| Aug 14, 2018 | Maxim Group | main | Buy | Buy |
About Titan Medical Inc.
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Canada
- Website
- titanmedicalinc.com
News
- Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- 3 Common Myths About Penny Stocks Debunked
- Stocks That Hit 52-Week Lows On Wednesday
- Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
- Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
- Titan Medical Inc. (TMDI) Q3 2022 Earnings Call Transcript
- Earnings Scheduled For November 10, 2022
- Titan Medical to Issue Third Quarter 2022 Financial Results on November 10, 2022
- Titan Medical to Present at the H.C. Wainwright Global Investment Conference
Your note
Sign in to keep a note on TMDI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Carrea (Tammy) | Senior Officer of Issuer | Acquisition or disposition in the public market | Aug 30, 2022 | 0 |
| Cataford (Paul G) | Director of Issuer | Acquisition or disposition in the public market | Jul 12, 2022 | 136,762 |
| Galfetti (Kristen) | Senior Officer of Issuer | Conversion or exchange | Aug 30, 2022 | 55,436 |
| Seibert (Christopher) | Senior Officer of Issuer | Conversion or exchange | Aug 30, 2022 | 44,298 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Essex LLC | 2.55% | 2,857,640 | 400.07K | Dec 30, 2022 |
| Alphaq Advisors LLC | 0.23% | 255,587 | 35.78K | Dec 30, 2022 |
| Kingsbury Capital Investment Advisors LLC | 0.20% | 224,288 | 31.40K | Sep 29, 2022 |
| Morgan Stanley | 0.18% | 198,429 | 27.78K | Dec 30, 2022 |
| Bank of America Corporation | 0.11% | 126,004 | 17.64K | Dec 30, 2022 |
| JP Morgan Chase & Company | 0.09% | 96,200 | 13.47K | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.07% | 76,620 | 10.73K | Nov 29, 2022 |